ReutersSanofi and Medtronic team up on diabetes drug-device combinationReutersPARIS (Reuters) – French drugmaker Sanofi said on Saturday it was teaming up with U.S. medical device maker Medtronic in diabetes. The announcement comes as Sanofi seeks to defend its No.2 spot in a global diabetes market worth over $40 billion, at a …Sanofi, Medtronic join on diabetes drugs, devicesWashington PostSanofi Joins Medtronic to Develop New Diabetes DevicesBloombergSanofi and Medtronic to Form Strategic Alliance in Diabetes to Improve Patient …Wall Street Journalall 5 news articles …Read Full Story
Sanofi and Medtronic team up on diabetes drug-device combination - Reuters
Real Estate of Cebu
